Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Yong Guo, Yiwen Du, Hongbing Ma, Yuping Gong, Ting Niu

Blood (2024) 144 (Supplement 1): 6006.

https://doi.org/10.1182/blood-2024-207662

Published: 2024

Journal Articles

Venetoclax Plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for Elderly or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia: A Multicenter, Prospective Study

Hongbing Ma, Yiwen Du, Jianjun Li, Jin Rao, Yong Guo, Yunfan Yang, Duanzhong Zhang, Jia Wang, Yi Liao, Yuping Gong

Blood (2024) 144 (Supplement 1): 2898.

https://doi.org/10.1182/blood-2024-202318

Published: 2024

Journal Articles

Long-Term Sovleplenib Treatment of Adults with Primary Immune Thrombocytopenia in China

Blood (2024) 144 (Supplement 1): 2558.

https://doi.org/10.1182/blood-2024-204447

Published: 2024

Journal Articles

Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score ≥2: A Prospective Multicenter Study

Li Bao, Min-qiu Lu, Peng Liu, Yu-Tong Wang, Junling Zhuang, Mei Zhang, Zhongjun Xia, Zhenling Li, Ying Yang, Zhenyu Yan, Hongmei Jing, Wenming Chen, Hebing Zhou, Rong Fu, Yuping Gong, Wenrong Huang, Yongqing Zhang

Blood (2022) 140 (Supplement 1): 12564–12565.

https://doi.org/10.1182/blood-2022-168068

Published: 2022

Journal Articles

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Blood (2021) 138 (Supplement 1): 16.

https://doi.org/10.1182/blood-2021-149895

Published: 2021

Journal Articles

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

Yunfan Yang, MD, Zhongqing Zou, MD, Ting Liu, MD PhD, Yongqian Jia, PhD, Ting Niu, MD PhD, Huanling Zhu, MD, Yu Wu, MD, Yuping Gong, MD, Hong Chang, MD, Jie Ji, MD, Jian Li, MD, Ling Pan

Blood (2019) 134 (Supplement_1): 5384.

https://doi.org/10.1182/blood-2019-128553

Published: 2019

Journal Articles

Clinical Significance of Germ Line and Acquired Somatic Mutations of 30 High Frequency Genes in Hematologic Malignancies

Nanchen Zhang, Yuping Gong, MD

Blood (2018) 132 (Supplement 1): 5126.

https://doi.org/10.1182/blood-2018-99-117766

Published: 2018

Journal Articles

Lncrna RP1-68D18.2 Promotes K562 Cell Line Resistance to Imatinib through CD44 and Its Downstream Signal Molecules

Tianyou Yan, Yuping Gong, MD

Blood (2018) 132 (Supplement 1): 5149.

https://doi.org/10.1182/blood-2018-99-115865

Published: 2018

Journal Articles

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

Blood (2016) 128 (22): 4882.

https://doi.org/10.1182/blood.V128.22.4882.4882

Published: 2016

Journal Articles

High-Expressing Cftr Interacts with HDAC2 to Promote the Development of Ph+ Leukemia through HDAC2-Mediated PENT Pathway

Tianyou Yan, MD, Yuping Gong, MD PhD

Blood (2016) 128 (22): 5114.

https://doi.org/10.1182/blood.V128.22.5114.5114

Published: 2016

Journal Articles

The High Expression of CFTR in Ph+ Acute Leukemia Regulates the BCR-ABL and Wnt/ -Catenin Signaling Pathway Via Interaction with PP2A Protein

Xi Yang, Yuping Gong, MDPhD

Blood (2015) 126 (23): 1252.

https://doi.org/10.1182/blood.V126.23.1252.1252

Published: 2015

Journal Articles

The Anti-Leukemia Role and Mechanism of Ribavirin in Ph+ Leukemia

Yuping Gong, MDPhD, Fangfang Shi

Blood (2014) 124 (21): 5278.

https://doi.org/10.1182/blood.V124.21.5278.5278

Published: 2014

Journal Articles

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Ling Pan, MD, PhD, Meng Chen, Yongqian Jia, MD, PhD, Xu Cui, MD, Ting Niu, MD, PhD, Hong Chang, MD, PhD, Hongbing Ma, MD, Jianjun Li, MD, Yuping Gong, MD, PhD, Xinchuan Chen, MD, Ting Liu, MD, PhD

Blood (2013) 122 (21): 5001.

https://doi.org/10.1182/blood.V122.21.5001.5001

Published: 2013

Journal Articles

Curcumin Potentiates Antitumor Activity of Imatinib Via Inhibition of the AKT/mTOR Signaling Pathway and Down-Regulation of Bcr-Abl Gene in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuping Gong, MD, PhD, Yong Guo, MD, PhD, Ting Niu, MD, PhD

Blood (2012) 120 (21): 3559.

https://doi.org/10.1182/blood.V120.21.3559.3559

Published: 2012

Journal Articles

MEK 1/2 Inhibitor U0126 Reversed Imatinib Resistance in IM-Resistant K562R

Yuping Gong, MD, PhD, Juan Lin, Ting Niu, MD, PhD

Blood (2012) 120 (21): 4914.

https://doi.org/10.1182/blood.V120.21.4914.4914

Published: 2012

Journal Articles

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Yongqian Jia, MD, Bing Xiang, MD, Xiaodong Wang, MD, Jianjun Li, MD, Chuan He, MD, Yi Su, MD, Hong Lu, MD, Ting Niu, MD, Jie Huang, MD, Xinchuan Chen, MD, Xu Cui, MD, Yuping Gong, MD, PhD, Huanling Zhu, MD, Ting Liu, MD

Blood (2011) 118 (21): 3714.

https://doi.org/10.1182/blood.V118.21.3714.3714

Published: 2011

Journal Articles

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Ting Liu, MD, Pu Kuang, MD, Tian Dong, MD, Bing Xiang, MD, Jianjun Li, MD, Xinchuan Chen, MD, Chuan He, MD, Hongbing Ma, MD, Jie Ji, MD, Yuping Gong, MD, PhD, Hong Chang, MD, Yu Wu, MD, PhD, Huanling Zhu, MD, Yuchun Wang, MD, PhD

Blood (2011) 118 (21): 4243.

https://doi.org/10.1182/blood.V118.21.4243.4243

Published: 2011

Journal Articles

Sirolimus Combined with Dexamethasone for the Treatment of a Patient with Interferon Resistant Hydroa Vacciniform-Like Lymphoma

Zhigang Liu, MD, Yongqian Jia, MD, Yuping Gong, MD, PhD, Yong Guo, MD, Jiazhuo Liu, MD, Ting Liu, MD

Blood (2011) 118 (21): 4992.

https://doi.org/10.1182/blood.V118.21.4992.4992

Published: 2011

Journal Articles

The Role of Transcription Factor SCL/TAL-1 in the Hematopoiesis of Human Cord Blood Hematopoietic Stem Cell

Yuping Gong, Ruiqing Zhoui, Ting Niu, M.D., Ph.D.

Blood (2011) 118 (21): 4795.

https://doi.org/10.1182/blood.V118.21.4795.4795

Published: 2011

Journal Articles

The Transcription Factor SCL/TAL-1 Plays a Positive Role in the Erythropoietic Differentiation Via MEK/ERK Pathway in EPO-Induced K562 Cell Line

Yuping Gong, Ruiqing Zhou, Ting Niu, M.D., Ph.D.

Blood (2011) 118 (21): 4799.

https://doi.org/10.1182/blood.V118.21.4799.4799

Published: 2011

NARROW

Single-Center Retrospective Clinical Evaluation of 7-Day Venetoclax Combined with Decitabine and CAG Regimen for AML Older Than 60 Years

Venetoclax Plus D-CAG (decitabine, cytarabine, aclarubicin, G-CSF) for Elderly or Unfit Patients with Newly Diagnosed Acute Myeloid Leukemia: A Multicenter, Prospective Study

Long-Term Sovleplenib Treatment of Adults with Primary Immune Thrombocytopenia in China

Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Ixazomib, Pegylated Liposomal Adriamycin, and Dexamethasone(IDd) in Elderly Frail Newly Diagnosed Multiple Myeloma with GA Score ≥2: A Prospective Multicenter Study

Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study

Efficacy Analysis of Ruxolitinib in Treatment of 72 Patients with Myelofibrosis in a Chinese Institution

Clinical Significance of Germ Line and Acquired Somatic Mutations of 30 High Frequency Genes in Hematologic Malignancies

Lncrna RP1-68D18.2 Promotes K562 Cell Line Resistance to Imatinib through CD44 and Its Downstream Signal Molecules

Retrospective Treatment Analysis of a Series of 104 Patients with Adult Onset Hemophagocytic Lymphohistiocytosis in a Single Institution of China

High-Expressing Cftr Interacts with HDAC2 to Promote the Development of Ph+ Leukemia through HDAC2-Mediated PENT Pathway

The High Expression of CFTR in Ph+ Acute Leukemia Regulates the BCR-ABL and Wnt/ -Catenin Signaling Pathway Via Interaction with PP2A Protein

The Anti-Leukemia Role and Mechanism of Ribavirin in Ph+ Leukemia

Decitabine Combined With Chemotherapy For The Treatment Of Refractory Acute Myeloid Leukemia: a Pilot Phase 1 Clinical Study

Curcumin Potentiates Antitumor Activity of Imatinib Via Inhibition of the AKT/mTOR Signaling Pathway and Down-Regulation of Bcr-Abl Gene in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

MEK 1/2 Inhibitor U0126 Reversed Imatinib Resistance in IM-Resistant K562R

An Escalated Dose of Bortezomib Plus Second Line Chemotherapy for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma,

Imatinib 400mg Daily Combined with Vindesine and Dexamethasone As Induction and Maintenance Therapy for Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia

Sirolimus Combined with Dexamethasone for the Treatment of a Patient with Interferon Resistant Hydroa Vacciniform-Like Lymphoma

The Role of Transcription Factor SCL/TAL-1 in the Hematopoiesis of Human Cord Blood Hematopoietic Stem Cell

The Transcription Factor SCL/TAL-1 Plays a Positive Role in the Erythropoietic Differentiation Via MEK/ERK Pathway in EPO-Induced K562 Cell Line

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only